Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

betapharm Arzneimittel GmbH

Division of Dr. Reddy's Laboratories Ltd.
www.betapharm.com

Latest From betapharm Arzneimittel GmbH

Pfizer’s Ruxience Rituximab Biosimilar Gets CHMP Nod

Pfizer has received a positive opinion from the CHMP recommending granting a pan-European marketing authorization for its Ruxience rituximab biosimilar version of MabThera. At the same time, CHMP nods for hybrid medicines were received by SciPharm and Teva, while Mylan, Betapharm and Accord saw generics endorsed by the committee.

Biosimilars Generic Drugs

EU Firsts Beckon For Alnylam & Novo; Wins For A Raft Of Others

A plethora of new drugs moved closer to the EU market this week after the European Medicines Agency recommended that they should be approved.

Europe Approvals

Indian Firms May Want To Slow March Into China

New markets are opening up for Indian firms and China appears to be the flavor of the season, but gaining a strong foothold there is not expected to be even "half as easy" as in the US.

Commercial Outlook 2020

Ranitidine Recalls Begin As European Regulators Take Action

OTC ranitidine products are among the first to be recalled in Europe following the discovery of a human carcinogen in ranitidine-based drugs.With investigations underway worldwide, regulators across Europe are split into two camps: immediate action or wait and see.

Product Recalls Drug Safety
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Betapharm International
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Dr. Reddy's Laboratories Ltd.
  • Senior Management
  • Wolfgang Niedermaier, CEO
  • Contact Info
  • betapharm Arzneimittel GmbH
    Phone: (49)
    Augsburg,
    Germany
UsernamePublicRestriction

Register